Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,862,069
-
Total 13F shares
-
23,224,867
-
Share change
-
+23,224,867
-
Total reported value
-
$253,676,000
-
Price per share
-
$10.93
-
Number of holders
-
54
-
Value change
-
+$253,676,000
-
Number of buys
-
54
Institutional Holders of HilleVax, Inc. - Common Stock (HLVX) as of Q2 2022
As of 30 Jun 2022,
HilleVax, Inc. - Common Stock (HLVX) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,224,867 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Abingworth LLP, RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, Samsara BioCapital, LLC, BlackRock Inc., StepStone Group LP, and FRANKLIN RESOURCES INC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.